cellvie
herapeutic Mitochondria Transplantation (TMT) company
cellvie has raised €9.4M across 2 funding rounds from 4 investors, most recently a round in Sep 2025. Based in Zurich, Switzerland; active in Healthtech. Data as of 28 Oct 2026.
Zurich, Switzerlandwww.cellvie.bio ↗
Total raised
€9.4M
€9,374,884
Funding rounds
2
Investors
4
distinct backers
Active since
2023-02
latest 2025-09
Funding by year
EUR raised per yearcellvie — funding by year — interactive chart.
Data table
| cellvie — funding by year | |
|---|---|
| 2023 | €5.1M |
| 2025 | €4.3M |
Signals
High confidenceRaise-next likelihood36
base rate 30% for Other
- ▲ In typical raise window
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood15
base rate 11% (2+ rounds)
- ▲ Recent equity round, but funding momentum is down (may be rescue financing)
Timing: in window vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-09-10 | Other | €4.3M | Beiersdorf,Kizoo Technology Ventures,Taiho Ventures | View deal → |
| 2023-02-06 | Other | €5.1M | Kizoo Technology Ventures,Taiho Ventures | View deal → |
Related news
- cellvie Raises $5.5M in Financingfinsmes.com · 2023-02
- startupticker.ch
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData